Item 5. OTHER INFORMATION
2K characters. Original on sec.gov · Markdown
Item 5. OTHER INFORMATION
During the three months ended October 31, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) informed us of the adoption or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K), except as follows. On September 18, 2025, Sabastian Niles, President & Chief Legal Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c). Subject to certain conditions, the trading arrangement provides for the sale of up to 25% of the net shares (after withholding taxes) received by Mr. Niles upon vesting and settlement of restricted stock unit and performance-based restricted stock unit awards through September 30, 2026 (or the date all shares are sold under the arrangement, if earlier). On October 3, 2025, Sundeep Reddy, Executive Vice President & Chief Accounting Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 7,000 shares of the Company’s common stock, subject to certain conditions, through December 31, 2026 (or the date all shares are sold under the arrangement, if earlier). On October 10, 2025, Marc Benioff, Chair and Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 351,607 shares of the Company’s common stock, subject to certain conditions, through February 26, 2027 (or the date all shares are sold under the arrangement, if earlier).
Previous: Item 1A. RISK FACTORS · Next: Item 6. EXHIBITS